News & Updates
Filter by Specialty:
Osmotic-release oral system methylphenidate of little help in ADHD
Treatment with osmotic-release oral system methylphenidate falls short of reducing symptoms of attention-deficit hyperactivity disorder (ADHD) in young adult prisoners, as shown in a study.
Osmotic-release oral system methylphenidate of little help in ADHD
29 Dec 2022Psychological distress contributes to increased dementia risk
Individuals with symptoms of psychological distress are at increased risk of all-cause dementia, although this association is attenuated by the competing risk of death, according to a study.
Psychological distress contributes to increased dementia risk
23 Dec 2022Uric acid not linked to major depressive disorder
There appears to be no significant association between serum uric acid (SUA) and major depressive disorder (MDD), suggest the results of a meta-analysis and two-sample bidirectional Mendelian randomization (MR) study.
Uric acid not linked to major depressive disorder
15 Dec 2022COVID-19 vaccination boosts mental wellbeing during pandemic
Individuals who have received one or two doses of the COVID-19 vaccinations experience improved mental wellbeing during the pandemic, reports a recent Japan study.
COVID-19 vaccination boosts mental wellbeing during pandemic
15 Dec 2022Does fMRI neurofeedback improve symptoms, cognition in children with ADHD?
Nonpharmacological treatment with functional magnetic resonance imaging neurofeedback (fMRI-NF) of the right inferior frontal cortex (rIFC) does not seem effective in improving clinical symptoms or cognition in boys with attention deficit hyperactivity disorder (ADHD), reports a recent study.